Psychemedics Corporation – NASDAQ:PMD
Psychemedics stock price today
$2.67
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 19 minutes
Psychemedics stock price monthly change
+12.66%
month
Psychemedics stock price quarterly change
+12.66%
quarter
Psychemedics stock price yearly change
-7.61%
year
Psychemedics key metrics
Market Cap | 15.73M |
Enterprise value | 15.51M |
P/E | -3.36 |
EV/Sales | 0.71 |
EV/EBITDA | -11.64 |
Price/Sales | 0.69 |
Price/Book | 2.38 |
PEG ratio | 0.22 |
EPS | -0.77 |
Revenue | 21.59M |
EBITDA | -1.33M |
Income | -4.45M |
Revenue Q/Q | -8.56% |
Revenue Y/Y | -12.17% |
Profit margin | -20.64% |
Oper. margin | -13.7% |
Gross margin | 38.57% |
EBIT margin | -13.7% |
EBITDA margin | -6.17% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePsychemedics stock price history
Psychemedics stock forecast
Psychemedics financial statements
| Jun 2023 | 5.53M | -726K | -13.11% |
|---|---|---|---|
| Sep 2023 | 5.70M | -2.09M | -36.8% |
| Dec 2023 | 4.99M | -945K | -18.91% |
| Mar 2024 | 5.35M | -688K | -12.84% |
2.71%
Yield TTM
| Payout ratio | 0% |
|---|
| 2019 | 7.87% |
|---|---|
| 2020 | 3.53% |
| 2021 | 0.72% |
| 2022 | 4.3% |
| 2023 | 4.7% |
| Jun 2023 | 16386000 | 7.25M | 44.3% |
|---|---|---|---|
| Sep 2023 | 14104000 | 6.67M | 47.33% |
| Dec 2023 | 13270000 | 6.59M | 49.72% |
| Mar 2024 | 11152000 | 4.87M | 43.68% |
| Jun 2023 | -959K | -48K | -928K |
|---|---|---|---|
| Sep 2023 | -958K | -43K | -74K |
| Dec 2023 | 662K | 5K | -73K |
| Mar 2024 | -473K | 5K | -75K |
Psychemedics alternative data
| Aug 2023 | 133 |
|---|---|
| Sep 2023 | 133 |
| Oct 2023 | 133 |
| Nov 2023 | 133 |
| Dec 2023 | 133 |
| Jan 2024 | 133 |
| Feb 2024 | 133 |
| Mar 2024 | 133 |
| Apr 2024 | 133 |
| May 2024 | 116 |
| Jun 2024 | 116 |
| Jul 2024 | 116 |
Psychemedics other data
9.08%
-15.96%
of PMD is owned by hedge funds
11
-10
510.75K
-901.04K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2024 | 1409712 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | KAMIN PETER director, 10 percent owner: | Common Stock, $0.005 Par Value | 1,409,712 | $2.35 | $3,312,823 | ||
Sale | DOUCOT CHARLES M officer: Executiv.. | Common Stock, $.005 Par Value | 12,700 | $4.66 | $59,182 | ||
Purchase | SCHAFFER MICHAEL I officer: VP of La.. | Common Stock, $.005 Par Value | 100 | $4.95 | $495 | ||
Purchase | KAMIN PETER 10 percent owner | Common Stock | 1,800 | $6.72 | $12,096 | ||
Purchase | KAMIN PETER 10 percent owner | Common Stock | 3,808 | $6.72 | $25,590 | ||
Purchase | KAMIN PETER 10 percent owner | Common Stock | 1,950 | $6.72 | $13,104 | ||
Purchase | KAMIN PETER 10 percent owner | Common Stock | 8,100 | $6.72 | $54,432 | ||
Purchase | KAMIN PETER 10 percent owner | Common Stock | 627 | $6.52 | $4,088 | ||
Purchase | KAMIN PETER 10 percent owner | Common Stock | 15,152 | $6.52 | $98,791 | ||
Purchase | KAMIN PETER 10 percent owner | Common Stock | 11,706 | $6.52 | $76,323 |
| Patent |
|---|
Application Filling date: 21 Oct 2021 Issue date: 21 Apr 2022 |
Application Filling date: 13 Sep 2019 Issue date: 18 Feb 2021 |
-
What's the price of Psychemedics stock today?
One share of Psychemedics stock can currently be purchased for approximately $2.67.
-
When is Psychemedics's next earnings date?
Unfortunately, Psychemedics's (PMD) next earnings date is currently unknown.
-
Does Psychemedics pay dividends?
Yes, Psychemedics pays dividends and its trailing 12-month yield is 2.71% with 0% payout ratio. The last Psychemedics stock dividend of $0.05 was paid on 30 Dec 2021.
-
How much money does Psychemedics make?
Psychemedics has a market capitalization of 15.73M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 12.45% to 22.1M US dollars.
-
What is Psychemedics's stock symbol?
Psychemedics Corporation is traded on the NASDAQ under the ticker symbol "PMD".
-
What is Psychemedics's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Psychemedics?
Shares of Psychemedics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Psychemedics's key executives?
Psychemedics's management team includes the following people:
- Mr. Raymond C. Kubacki Chairman, Chief Executive Officer & Pres(age: 80, pay: $525,800)
- Mr. Charles M. Doucot IV Executive Vice President(age: 59, pay: $316,520)
- Dr. Michael I. Schaffer Ph.D. Vice President of Laboratory Operations(age: 80, pay: $282,700)
-
How many employees does Psychemedics have?
As Jul 2024, Psychemedics employs 116 workers, which is 13% less then previous quarter.
-
When Psychemedics went public?
Psychemedics Corporation is publicly traded company for more then 38 years since IPO on 22 Jan 1987.
-
What is Psychemedics's official website?
The official website for Psychemedics is psychemedics.com.
-
Where are Psychemedics's headquarters?
Psychemedics is headquartered at 289 Great Road, Acton, MA.
-
How can i contact Psychemedics?
Psychemedics's mailing address is 289 Great Road, Acton, MA and company can be reached via phone at 978 206 8220.
Psychemedics company profile:
Psychemedics Corporation
psychemedics.comExchange:
NASDAQ
Full time employees:
116
Industry:
Medical - Diagnostics & Research
Sector:
Healthcare
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine and Fentanyl. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts.
289 Great Road
Acton, MA 01720
Acton, MA 01720
CIK: 0000806517
ISIN: US7443752057
CUSIP: 744375205
